학술논문

What are the obligations of pharmaceutical companies in a global health emergency?
Document Type
Review Article
Source
In The Lancet 11-17 September 2021 398(10304):1015-1020
Subject
Review and Opinion
Viewpoint
Language
ISSN
0140-6736